New Delhi, May 3
Serum Institute of India (SII) on Monday endorsed the federal government assertion that 100 per cent advance of Rs 1,732.50 crore has been launched to the corporate on April 28 for 11 crore doses of the Covishield vaccine for May, June and July.
“We endorse this statement, & the authenticity of the information. We have been working closely with the Government of India for the past year & thank it for its support. We remain committed to ramping up our vaccine production to save every life we can,” SII stated on Twitter.
The firm’s response got here after the Health Ministry in an announcement refuted allegations that it has not positioned any recent orders for the Covishield vaccine with SII.
The Health Ministry earlier stated it has paid your entire advance of Rs 1,732.50 crore to SII for 11 crore doses of Covishield vaccine for three months—May, June and July.
The quantity, which after TDS was Rs 1,699.50 crore, was acquired by the SII on April 28 itself, it stated.
As on date, towards the final order of 10 crore doses for provides of Covishield vaccine, 8.744 crore doses have been delivered until May 3, the ministry stated, including, media reviews alleging that the Centre has not positioned any recent order for COVID-19 vaccines are “incorrect and not based on facts”.
Additionally, 100 per cent advance of Rs 787.50 crore (after TDS Rs 772.50 crore) was launched on April 28 to Bharat Biotech India Ltd (BBIL) for 5 crore Covaxin doses throughout May, June and July. The quantity was acquired by them on April 28.
As on date towards the final order of two crore doses for provides of Covaxin vaccine, 0.8813 crore doses have been delivered until May 3, the ministry stated.
“Hence, to say that fresh orders have not been placed by the Government of India is not correct,” it stated.
As of May 2, the Centre has supplied extra 16.54 crore vaccine doses to states and union territories free of value. More than 78 lakh doses are nonetheless obtainable with them to be administered, the ministry stated.
“More than 56 lakh doses, in addition, will be received by states and UTs in the next three days,” it acknowledged.
Under the Liberalised Pricing and Accelerated National COVID-19 Vaccination Strategy, the Government of India would proceed to obtain its share of 50 per cent of the month-to-month Central Drugs Laboratory (CDL) cleared vaccines and would proceed to make it obtainable to the state governments completely free of value as was being carried out earlier, the ministry acknowledged. PTI